← All trials
NCT03757117
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2016
- Primary completion
- Mar 31, 2018
- Completion date
- Mar 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 220
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Asociación Civil Impacta Salud y Educación, PeruLead sponsor
- AmFARCollaborator
- The Fenway InstituteCollaborator
- The Fenway InstituteOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.